Thrivent Financial for Lutherans’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $5.21M | Buy |
65,068
+7,067
| +12% | +$583K | 0.01% | 891 |
|
|
2025
Q4 | $4.95M | Buy |
58,001
+5,202
| +10% | +$427K | 0.01% | 948 |
|
|
2025
Q3 | $4.11M | Buy |
52,799
+1,942
| +4% | +$152K | 0.01% | 934 |
|
|
2025
Q2 | $3.98M | Buy |
50,857
+10,045
| +25% | +$749K | 0.01% | 927 |
|
|
2025
Q1 | $2.96M | Sell |
40,812
-1,117,938
| -96% | -$80M | 0.01% | 1056 |
|
|
2024
Q4 | $85.7M | Sell |
1,158,750
-99,212
| -8% | -$6.94M | 0.17% | 154 |
|
|
2024
Q3 | $83M | Sell |
1,257,962
-87,276
| -6% | -$6.34M | 0.16% | 183 |
|
|
2024
Q2 | $124M | Sell |
1,345,238
-19,997
| -1% | -$1.77M | 0.25% | 86 |
|
|
2024
Q1 | $130M | Sell |
1,365,235
-303,401
| -18% | -$25.5M | 0.26% | 87 |
|
|
2023
Q4 | $127M | Sell |
1,668,636
-3,870
| -0.2% | -$269K | 0.28% | 83 |
|
|
2023
Q3 | $116M | Sell |
1,672,506
-2,818
| -0.2% | -$226K | 0.28% | 87 |
|
|
2023
Q2 | $158M | Buy |
1,675,324
+28,174
| +2% | +$2.45M | 0.36% | 49 |
|
|
2023
Q1 | $136M | Buy |
1,647,150
+419,452
| +34% | +$33M | 0.33% | 63 |
|
|
2022
Q4 | $91.6M | Sell |
1,227,698
-29,488
| -2% | -$2.27M | 0.24% | 106 |
|
|
2022
Q3 | $104M | Sell |
1,257,186
-764,833
| -38% | -$73.6M | 0.29% | 75 |
|
|
2022
Q2 | $192M | Buy |
2,022,019
+134,191
| +7% | +$13.9M | 0.51% | 22 |
|
|
2022
Q1 | $222M | Buy |
1,887,828
+155,124
| +9% | +$17.4M | 0.43% | 37 |
|
|
2021
Q4 | $224M | Sell |
1,732,704
-64,630
| -4% | -$7.54M | 0.43% | 38 |
|
|
2021
Q3 | $203M | Sell |
1,797,334
-17,768
| -1% | -$2.03M | 0.41% | 42 |
|
|
2021
Q2 | $188M | Sell |
1,815,102
-105,545
| -5% | -$9.95M | 0.38% | 43 |
|
|
2021
Q1 | $161M | Buy |
1,920,647
+7,105
| +0.4% | +$601K | 0.35% | 49 |
|
|
2020
Q4 | $175M | Sell |
1,913,542
-149,633
| -7% | -$12.4M | 0.4% | 44 |
|
|
2020
Q3 | $165M | Sell |
2,063,175
-6,426
| -0.3% | -$501K | 0.44% | 38 |
|
|
2020
Q2 | $143M | Buy |
2,069,601
+7,746
| +0.4% | +$550K | 0.43% | 37 |
|
|
2020
Q1 | $130M | Buy |
2,061,855
+28,368
| +1% | +$2.05M | 0.47% | 34 |
|
|
2019
Q4 | $158M | Sell |
2,033,487
-1,018,698
| -33% | -$79.5M | 0.45% | 35 |
|
|
2019
Q3 | $224M | Sell |
3,052,185
-111,450
| -4% | -$7.83M | 0.69% | 21 |
|
|
2019
Q2 | $195M | Buy |
3,163,635
+31,743
| +1% | +$1.92M | 0.59% | 26 |
|
|
2019
Q1 | $200M | Sell |
3,131,892
-17,118
| -0.5% | -$977K | 0.63% | 28 |
|
|
2018
Q4 | $161M | Buy |
3,149,010
+560,538
| +22% | +$28.4M | 0.58% | 33 |
|
|
2018
Q3 | $150M | Sell |
2,588,472
-50,577
| -2% | -$2.47M | 0.47% | 42 |
|
|
2018
Q2 | $128M | Buy |
2,639,049
+801,210
| +44% | +$37.4M | 0.42% | 48 |
|
|
2018
Q1 | $85.5M | Buy |
1,837,839
+157,845
| +9% | +$6.85M | 0.29% | 76 |
|
|
2017
Q4 | $63.1M | Buy |
1,679,994
+291
| +0% | +$10.7K | 0.21% | 105 |
|
|
2017
Q3 | $61.2M | Buy |
1,679,703
+49,593
| +3% | +$1.89M | 0.22% | 115 |
|
|
2017
Q2 | $64.2M | Sell |
1,630,110
-481,560
| -23% | -$17.6M | 0.27% | 98 |
|
|
2017
Q1 | $66.2M | Sell |
2,111,670
-163,620
| -7% | -$5.12M | 0.29% | 86 |
|
|
2016
Q4 | $71.1M | Buy |
2,275,290
+390,360
| +21% | +$12.6M | 0.32% | 82 |
|
|
2016
Q3 | $75.7M | Sell |
1,884,930
-28,740
| -2% | -$1.08M | 0.35% | 75 |
|
|
2016
Q2 | $63.6M | Sell |
1,913,670
-434,670
| -19% | -$14.9M | 0.3% | 84 |
|
|
2016
Q1 | $69M | Buy |
2,348,340
+185,040
| +9% | +$5.11M | 0.33% | 78 |
|
|
2015
Q4 | $57M | Buy |
2,163,300
+41,880
| +2% | +$1.09M | 0.27% | 96 |
|
|
2015
Q3 | $50.3M | Buy |
2,121,420
+1,110,120
| +110% | +$26.8M | 0.26% | 97 |
|
|
2015
Q2 | $24M | Buy |
1,011,300
+51,600
| +5% | +$1.16M | 0.13% | 180 |
|
|
2015
Q1 | $22.8M | Buy |
959,700
+600
| +0.1% | +$13.5K | 0.13% | 193 |
|
|
2014
Q4 | $20.4M | Buy |
959,100
+944,100
| +6,294% | +$19M | 0.11% | 210 |
|
|
2014
Q3 | $255K | Hold |
15,000
| – | – | ﹤0.01% | 1457 |
|
|
2014
Q2 | $215K | Buy |
+15,000
| New | +$203K | ﹤0.01% | 1595 |
|
|
2013
Q3 | – | Sell |
-24,000
| Closed | -$269 | – | 1555 |
|
|
2013
Q2 | $269 | Buy |
+24,000
| New | +$284K | ﹤0.01% | 1271 |
|
Other funds holding EW
VCM
VPM
Thrivent Financial for Lutherans's EW Position: Q1 2026 in Review
Thrivent Financial for Lutherans increased its Edwards Lifesciences (EW) stake by 12% in Q1 2026, buying an estimated $583K and bringing the position to 65,068 shares worth $5.21M. The position accounts for 0.01% of the portfolio, ranked #891.
Thrivent Financial for Lutherans first reported a position in EW in Q2 2013 and has held it in 49 quarters since. The position peaked at $224M in Q4 2021. 1,285 funds tracked by Wall St. Rank hold EW as of Q1 2026.
- Thrivent Financial for Lutherans held 65,068 shares of Edwards Lifesciences worth $5.21M as of Q1 2026.
- Thrivent Financial for Lutherans bought 7,067 Edwards Lifesciences shares in Q1 2026, an estimated $583K.
- Edwards Lifesciences made up 0.01% of Thrivent Financial for Lutherans's portfolio in Q1 2026, its #891 holding.
- Thrivent Financial for Lutherans first reported a position in Edwards Lifesciences in Q2 2013 and has held it in 49 quarters since.
- Thrivent Financial for Lutherans's Edwards Lifesciences position peaked at $224M in Q4 2021.
- 1,285 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.
Based on Thrivent Financial for Lutherans's 13F filing for Q1 2026, filed 1 May 2026.